Viewing Study NCT07457359


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-07-09 @ 4:24 AM
Study NCT ID: NCT07457359
Status: RECRUITING
Last Update Posted: 2026-03-09
First Post: 2026-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Toripalimab Plus SBRT for Chemo-Resistant Triple-Negative Breast Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None TNBC, Triple Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chemo-resistance View
None neoadjuvant SBRT View